SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-005699
Filing Date
2014-01-29
Accepted
2014-01-29 21:01:40
Documents
2
Period of Report
2014-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2809
2 POA DOCUMENT poa.txt EX-24.3_503790 4708
  Complete submission text file 0001209191-14-005699.txt   8902
Mailing Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472
Business Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMICUS THERAPEUTICS, INC. 6 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Dentzer James E (Reporting) CIK: 0001400977 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36281 | Film No.: 14558457